Aligning AI Practices in Drug Development
The EMA and FDA have released joint guiding principles for the safe use of AI in drug development, aiming to harmonize regulatory practices. These principles emphasize ethical values, data governance, and flexibility across various AI applications to enhance innovation in the pharmaceutical sector.